NanoBio Corporation - Company & Market Research Reports

NanoBio Corporation, a biopharmaceutical company, focuses on developing and commercializing vaccines and anti-infective treatments. The company’s NanoStat vaccine technology employs a novel oil-in-water nanoemulsion (NE) that can incorporate, deliver, and adjuvant multiple antigen types. It offers NE vaccines for several respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, chlamydia, and HIV. The company was founded in 1999 and is based in Ann Arbor, Michigan.